Quick Answer
BPH treatment is chosen according to symptoms, prostate enlargement and risk of progression—not prostate size alone. Mild, minimally bothersome symptoms may need only monitoring and lifestyle measures. Bothersome symptoms can be treated with medicines, while procedures or surgery are reasonable when symptoms remain unacceptable, complications develop, or a patient prefers a more durable procedural solution.
Alpha blockers work relatively quickly but do not shrink the prostate or prevent urinary retention. Finasteride or dutasteride act slowly, can shrink an enlarged prostate and reduce the long-term risk of retention and BPH surgery in appropriately selected men. Tadalafil 5 mg daily can improve LUTS with or without erectile dysfunction but does not substantially shrink the prostate or prevent progression.
Modern procedures range from ejaculation-preserving options such as UroLift, Rezūm and Aquablation to highly durable tissue-removing procedures such as TURP and HoLEP. The best choice depends on prostate anatomy, severity, bladder function, sexual priorities, durability, recovery and retreatment risk.
Being told that you have an enlarged prostate (benign prostatic hyperplasia, BPH) does not automatically mean that you need medication or surgery.
It is also important to separate BPH from lower urinary tract symptoms (LUTS). BPH is a benign enlargement/proliferation of prostate tissue. LUTS are symptoms such as weak stream, urgency, frequency and nocturia. Those symptoms can come from the prostate, bladder, urethra, medications, infection or neurological disease.
This is why the 2026 AUA (American Urological Association) guideline emphasizes that treatment begins with a correct evaluation and shared decision-making, rather than simply treating every urinary symptom as prostate obstruction.
First Question: Do You Need BPH Treatment at All?
The main reason to start treatment is usually that symptoms are bothersome enough to affect quality of life, or that BPH is causing complications or meaningful obstruction.
Mild / Minimally Bothersome
Watchful waiting plus lifestyle and self-care measures is often appropriate when there are no important complications.
Bothersome Symptoms
Medication, a minimally invasive procedure or surgery may be appropriate depending on the clinical picture and your preferences.
Risk of Progression
A clearly enlarged gland, higher PSA related to gland volume, older age, lower flow and other features may shift treatment toward a 5-alpha-reductase inhibitor or combination therapy.
Complications / Severe Obstruction
Retention, kidney impairment from obstruction, recurrent infection, bladder stones or recurrent BPH-related bleeding may make procedural treatment more important.
How Is the Right BPH Treatment Chosen?
Your doctor or urologist may consider:
- how severe and bothersome your symptoms are;
- whether symptoms are mainly voiding (weak stream, hesitancy, straining) or storage (urgency, frequency, nocturia);
- prostate volume and anatomy, including a median lobe when relevant;
- urinary flow and post-void residual (PVR);
- whether the bladder muscle is functioning adequately;
- risk of acute urinary retention and future BPH surgery;
- kidney function and BPH complications;
- blood pressure and cardiovascular medicines;
- erectile function and whether preserving ejaculation is important;
- how quickly you want improvement;
- how much durability you want versus accepting a higher retreatment risk;
- anesthesia/recovery preferences;
- and local urological expertise.
Two Measurements That Are Often Misunderstood
Prostate size: a large prostate can cause few symptoms, while a smaller prostate can cause significant obstruction.
PVR: residual urine is measured in milliliters. A high PVR can result from bladder-outlet obstruction, weak bladder muscle, or both. There is no single PVR number that by itself automatically means surgery is required.
A Practical BPH Treatment Path
→ Watchful waiting + lifestyle/self-care.
→ Often an alpha blocker, depending on blood pressure, adverse-effect risk and treatment priorities.
→ Consider finasteride/dutasteride, often with an alpha blocker when faster symptom relief is also needed.
→ Tadalafil 5 mg daily may be useful if there is no nitrate or other important cardiovascular contraindication.
→ Selected men may benefit from a bladder-directed medicine such as an antimuscarinic or beta-3 agonist, with attention to PVR and retention risk.
→ Compare UroLift, Rezūm, Aquablation, PAE, TURP, HoLEP, laser procedures or simple prostatectomy according to anatomy and goals.
1. Watchful Waiting and Lifestyle Measures
If your urinary symptoms are mild, or even moderate but are not affecting your quality of life very much, treatment does not always need to begin with medication or surgery.
In these situations, the EAU (European Association of Urology) recommends what we call watchful waiting. This does not mean ignoring the prostate or simply waiting for things to become worse. It means monitoring your symptoms while making practical changes that may help you urinate more comfortably.
I usually explain to patients that some of the simplest measures can make a noticeable difference.
- Try to avoid drinking large amounts of fluid in the evening, especially before bedtime. However, do not reduce your fluids so much that you become dehydrated.
- Reduce coffee, tea and other caffeinated drinks if you notice that they increase urgency, frequent urination or waking during the night to urinate.
- Limit alcohol if it makes your urinary symptoms worse. Alcohol can increase urine production and may contribute to nighttime urination.
- Try double voiding when necessary. After you finish urinating, wait a short moment, relax, and try once more. Some men find this helps them empty the bladder more completely.
- Do not routinely hold your urine for very long periods. Go to the bathroom when you reasonably need to.
- Treat constipation. A full bowel can put additional pressure on the bladder and sometimes make urinary symptoms more troublesome.
- Stay physically active. Regular movement and exercise are good for your general health and may also support better urinary function.
- Review your medications. Some decongestants, antihistamines and other medicines can make urination more difficult. Do not stop prescribed medication on your own, but discuss it with your doctor if you notice a connection.
- Keep a 3-day bladder diary if nighttime urination is a major problem. Write down when and how much you drink, when you urinate, and how often you wake during the night. This can give your doctor valuable information about what is actually causing the nocturia.
The important point is that watchful waiting should still be active care. We continue to follow your symptoms, and if they become more bothersome, your urine flow deteriorates, you begin retaining urine, or complications develop, we can reconsider whether medication or a procedure would be more appropriate.
For many men with relatively mild symptoms, however, these measures may be enough to keep the condition comfortable and manageable for quite some time.
2. BPH Medications: What Each Class Actually Does
When I discuss BPH medications with my patients, I like to make one point clear from the beginning: not all prostate medicines do the same job. Some work quickly to improve urination, some gradually shrink the prostate, and others mainly target bladder symptoms such as urgency and frequency.
The right medication therefore depends not only on how bothersome your symptoms are, but also on the size of your prostate, your risk of progression, your other medical conditions, and which side effects are most important to you.
Alpha Blockers: Fast Symptom Relief
Alpha blockers are often used when a man wants relatively quick relief from urinary symptoms. Common examples include tamsulosin, alfuzosin, silodosin, doxazosin and terazosin.
These medicines do not physically remove prostate tissue. Instead, they relax the smooth muscle around the prostate and bladder outlet. This reduces resistance to urine flow, which is why many patients begin to notice an improvement within several days.
What alpha blockers can do well:
- reduce bothersome lower urinary tract symptoms (LUTS);
- improve urinary flow;
- and usually begin working relatively quickly.
However, I also explain that alpha blockers have an important limitation: they do not significantly shrink the prostate. They improve the way urine passes through the prostate, but they do not substantially change the underlying prostate enlargement.
This means that alpha blockers generally:
- do not prevent long-term prostate growth;
- do not significantly reduce the future risk of acute urinary retention;
- and do not provide the same long-term protection against BPH surgery as medications that shrink the prostate.
Possible side effects include dizziness, a fall in blood pressure when standing up, and changes in ejaculation. Ejaculatory problems are particularly associated with the more prostate-selective medicines such as tamsulosin and silodosin.
There is also one practical point that patients sometimes overlook. If you take an alpha blocker now, or have taken one in the past, tell your ophthalmologist before cataract surgery. These medicines can be associated with a condition called intraoperative floppy iris syndrome, which the eye surgeon needs to know about before the operation.
5-Alpha-Reductase Inhibitors: Shrinking the Prostate Over Time
Finasteride and dutasteride work very differently from alpha blockers. They reduce the effect of dihydrotestosterone, or DHT, which is an important hormone involved in prostate growth.
I usually tell patients to think of these medicines as a long-term treatment rather than a quick-relief treatment. They work gradually over several months.
According to the EAU (European Association of Urology), long-term treatment with a 5-alpha-reductase inhibitor can:
- reduce prostate volume by approximately 18–28%;
- lower PSA levels by approximately 50% after around 6–12 months;
- gradually improve urinary symptoms and urine flow;
- reduce the risk of acute urinary retention;
- and reduce the likelihood of eventually needing BPH surgery.
These medicines therefore make the most sense when the prostate is genuinely enlarged and there is a meaningful risk that BPH will continue to progress.
The AUA (American Urological Association) commonly considers evidence such as a prostate volume of roughly 30 cc or greater, a PSA above approximately 1.5 ng/mL as a possible marker of enlargement, or enlargement found during examination. The EAU gives a prostate volume above approximately 40 mL as one practical example of increased progression risk.
The important thing to understand is that finasteride and dutasteride require patience. Unlike alpha blockers, which may help within days, the benefit of these medications usually develops over months.
Possible sexual side effects can include reduced libido, erectile dysfunction and changes in ejaculation. These effects do not occur in every patient, but they should be discussed before starting treatment.
PSA Must Be Interpreted Differently With Finasteride or Dutasteride
This is something I particularly want patients to understand.
Finasteride and dutasteride commonly reduce PSA by approximately 50%. Therefore, once you have been taking one of these medicines for several months, your PSA result cannot simply be interpreted in the same way as it was before treatment.
Your doctor will usually establish a new PSA baseline after treatment has taken effect. If PSA subsequently begins to rise from that new baseline, the increase should be evaluated rather than automatically dismissed as being caused by the medication.
So, whenever another doctor orders a PSA test, make sure they know that you are taking finasteride or dutasteride.
Tadalafil 5 mg Daily: When Urinary Symptoms and Erectile Dysfunction Occur Together
Tadalafil is best known as a treatment for erectile dysfunction, but tadalafil 5 mg once daily is also a guideline-supported treatment for men with moderate-to-severe urinary symptoms related to BPH.
I often consider this option particularly relevant when a patient has both urinary symptoms and erectile dysfunction, because one medication may help address both problems.
Tadalafil can improve urinary symptom scores and erectile function. However, patients should understand that it usually does not significantly shrink the prostate, produce a major increase in peak urinary flow, or provide the same protection against urinary retention and future BPH surgery as a 5-alpha-reductase inhibitor.
Tadalafil must not be taken together with nitrate medications, which are sometimes prescribed for angina and other cardiovascular conditions. It may also be unsuitable for some patients with unstable cardiovascular disease. For this reason, I always recommend reviewing your complete medication list and cardiovascular history before starting treatment.
Alpha Blocker + 5-ARI Combination Therapy
For some men, combining an alpha blocker with a 5-alpha-reductase inhibitor provides the advantages of both treatments.
This approach can be particularly useful when a patient has:
- moderate-to-severe and bothersome urinary symptoms;
- a clearly enlarged prostate;
- and a meaningful risk that the BPH will progress over time.
I often explain the combination this way: the alpha blocker handles the short-term problem, while the 5-ARI works on the long-term problem.
The alpha blocker relaxes the prostate and bladder outlet and can provide relatively rapid symptom relief. Meanwhile, the 5-ARI gradually reduces prostate volume and helps lower the long-term risk of urinary retention and BPH surgery.
Long-term clinical studies have shown that this combination provides better protection against progression than an alpha blocker alone. The trade-off is that patients can also experience side effects associated with both medication classes.
When Urgency and Frequency Are the Main Problem
One of the most important things I tell patients is that not every urinary symptom in a man with an enlarged prostate is necessarily caused by prostate obstruction.
Some men are bothered mainly by bladder storage symptoms, such as:
- sudden urgency to urinate;
- frequent urination;
- difficulty postponing urination;
- or waking repeatedly at night.
In selected patients, particularly when these symptoms persist despite treatment of the prostate itself, doctors may consider medications directed more specifically at the bladder.
These can include:
- an antimuscarinic medication; or
- a beta-3 agonist such as mirabegron.
These medicines are designed to improve bladder storage symptoms. They do not shrink the prostate.
Before using them, we also need to think about how well the bladder is emptying. In men who already have a significant amount of urine remaining in the bladder after urination, known as the post-void residual (PVR), the risk of urinary retention needs to be considered carefully.
Are Antibiotics a Treatment for BPH?
No. This is a common point of confusion.
Benign prostatic hyperplasia is an enlargement of the prostate; it is not a bacterial infection. Therefore, antibiotics do not treat BPH itself.
Antibiotics are appropriate only when there is another reason to use them, such as a confirmed or strongly suspected bacterial urinary tract infection or bacterial prostatitis.
I would not recommend taking antibiotics simply because you have urinary symptoms or an enlarged prostate. The first step is to understand why the symptoms are occurring and then choose treatment for that specific cause.
The main message I want my patients to remember is that BPH treatment should be individualized. The medicine that is right for one man may not be the best choice for another. Prostate size, symptom pattern, PSA, bladder emptying, sexual function, cardiovascular health and personal priorities should all be considered when deciding on treatment.
3. Minimally Invasive Procedures and Surgery
The 2026 AUA procedural guideline emphasizes that procedures differ in efficacy, durability, sexual effects, recovery and retreatment risk. This is why “least invasive” is not automatically “best.”
Prostatic Urethral Lift (UroLift / PUL)
Small implants pull prostate tissue away from the urethra. PUL can preserve ejaculation and usually provides relatively quick recovery, but symptom/flow improvement is typically less than with tissue-removing surgery and retreatment is more common. EAU generally reserves it for selected prostates, commonly below about 70 mL and without an obstructing middle lobe under its guideline criteria.
Water-Vapor Thermal Therapy (Rezūm)
Steam is injected into selected prostate tissue, which shrinks gradually over weeks to months. Sexual function, including ejaculation, is often preserved. Early catheter use and temporary urinary irritation are common, and improvement is not immediate. Five-year randomized data have shown a relatively low surgical-retreatment rate (about 4–5%), but durability remains lower than the longest-established tissue-removing operations.
Aquablation / Robotic Waterjet Treatment
Aquablation removes prostate tissue with an image-guided high-velocity waterjet. EAU 2026 strongly recommends it as an alternative to TURP in prostates roughly 30–80 mL, particularly when preservation of ejaculation matters. Five-year trial data show durable symptom/flow improvement and high preservation of antegrade ejaculation; experience is also expanding in larger glands.
Prostate Artery Embolization (PAE)
PAE reduces prostate blood supply through an interventional-radiology procedure. It can be useful in selected men who prioritize a less invasive approach or have particular anesthetic/bleeding considerations. In general, symptom and flow improvement are less pronounced and retreatment is more frequent than after TURP, so careful counseling is important.
Transurethral Resection of the Prostate (TURP)
TURP remains one of the best-established BPH operations, particularly for moderate-sized prostates. It provides strong symptom and flow improvement with good durability. Bipolar TURP offers similar effectiveness to monopolar TURP with some perioperative safety advantages. Dry/retrograde ejaculation is common.
HoLEP / Anatomic Endoscopic Enucleation
HoLEP removes the obstructing adenoma through the urethra using a holmium laser. It is highly effective and durable across a wide range of prostate sizes and has a low retreatment rate. It is especially useful for large glands when expertise is available. Erections are often preserved, but dry/retrograde ejaculation is very common.
Simple Prostatectomy
Open or robotic simple prostatectomy removes the obstructing adenoma while leaving the prostate capsule. It is generally reserved for selected very large glands or anatomy not well suited to another approach. It is not the same operation as radical prostatectomy for prostate cancer.
Which Procedure Fits Which Priority?
| Option | Symptom / Flow Effect | Durability | Ejaculation | Typical Role |
|---|---|---|---|---|
| UroLift / PUL | Moderate | Lower than TURP/HoLEP; retreatment more likely | Usually preserved | Selected anatomy; prioritizing ejaculation and quick recovery |
| Rezūm | Moderate; gradual | Good mid-term, but less established than enucleation/TURP | Often preserved | Selected men wanting minimally invasive treatment |
| Aquablation | Strong | Good 5-year data | Better preservation than TURP in trials | Moderate/selected large glands; balancing efficacy and ejaculation |
| PAE | Moderate | Higher retreatment than TURP | Usually favorable | Selected men preferring a radiologic/minimally invasive option |
| TURP | Strong | Durable | Dry/retrograde ejaculation common | Established standard, especially moderate-size glands |
| HoLEP | Very strong | Very durable / low retreatment | Dry/retrograde ejaculation very common | Size-independent durable outlet treatment, including large glands |
| Simple prostatectomy | Very strong | Very durable | Ejaculatory change expected | Selected very large prostates |
Erection, Ejaculation and Orgasm Are Different
A procedure can preserve erections but still cause dry/retrograde ejaculation. When sexual function matters, ask specifically about erectile function, ejaculation and orgasm rather than simply asking whether a procedure “causes impotence.”
When Is a Procedure or Surgery Strongly Considered?
Procedural treatment may be appropriate because a patient wants more durable symptom relief, because medication has failed or caused adverse effects, or because complications make continued conservative treatment inappropriate.
Compelling BPH-related indications include:
- refractory or recurrent urinary retention;
- kidney impairment caused by BPH obstruction;
- recurrent urinary infections associated with obstruction;
- bladder stones related to outlet obstruction;
- recurrent significant bleeding attributable to BPH;
- and severe or refractory bothersome symptoms.
Importantly, surgery is not reserved only for emergencies. A well-informed patient with bothersome symptoms can reasonably choose a procedure because he prefers a durable solution over long-term medication.
BPH Surgery Is Not Radical Prostatectomy
Radical prostatectomy removes the prostate for prostate cancer. BPH surgery generally removes, enucleates, vaporizes, compresses or otherwise treats the benign tissue obstructing urine flow while leaving the cancer-style radical operation unnecessary.
What Tests Are Used Before Choosing Treatment?
The 2026 AUA guideline emphasizes that LUTS can arise from prostate, bladder, urethral or other pathology. Evaluation should therefore answer the clinical questions needed for the individual patient rather than ordering every available test.
Common components include:
- medical, urinary and medication history;
- validated symptom assessment such as the International Prostate Symptom Score (IPSS);
- physical examination;
- urinalysis;
- PSA when appropriate;
- post-void residual urine;
- urinary flow testing;
- prostate size/anatomy assessment when this affects treatment choice;
- cystoscopy when there is a specific indication;
- and urodynamics in selected cases when the cause of poor emptying is uncertain.
What Does the IPSS Tell You?
The IPSS measures symptom severity and quality-of-life impact. It is useful for documenting baseline symptoms and response to treatment, but it does not by itself diagnose BPH obstruction or determine that surgery is needed.
What Role Does PSA Play?
PSA is prostate-specific, not cancer-specific. BPH can raise PSA, but PSA alone cannot distinguish BPH from prostate cancer. It can also provide indirect information about prostate volume and progression risk. If finasteride or dutasteride is used, the expected PSA reduction must be incorporated into interpretation.
What About Saw Palmetto and Other Natural BPH Treatments?
Herbal products are widely marketed for BPH, but evidence depends heavily on the exact standardized preparation.
Overall, the best evidence shows that ordinary saw palmetto products provide little or no consistent benefit compared with placebo. EAU gives only a weak, formulation-specific recommendation for a particular hexane-extracted Serenoa repens preparation, with counseling that the expected benefit is modest.
Pygeum, pumpkin seed, stinging nettle and beta-sitosterol have limited or older evidence for symptom relief, but none has demonstrated the reliable prostate shrinkage or progression-prevention effects of finasteride/dutasteride.
Supplements Should Not Delay Proper Evaluation
A supplement cannot correct severe obstruction, kidney impairment, bladder stones or acute urinary retention. Tell your clinician about every supplement you use because formulations vary and interactions are possible.
Can BPH Be Prevented or “Cured” Permanently?
There is no proven way to guarantee that BPH will never develop.
Likewise, “cure” is not always the best word. Medications may control symptoms for years; 5-ARIs can alter progression risk; procedures can produce very durable relief; but prostate tissue, bladder function and urinary symptoms can change over time.
BPH does not turn into prostate cancer and does not itself increase prostate-cancer risk. A man can, however, have both conditions independently.
When Should You Arrange a Urology Review?
Arrange medical evaluation if:
- your urinary symptoms are becoming more bothersome;
- your stream is progressively weaker;
- you repeatedly feel unable to empty the bladder;
- nocturia is significantly disturbing sleep;
- medication is not helping enough;
- you have troublesome sexual or blood-pressure side effects from treatment;
- you want a more durable procedural solution;
- or your tests suggest significant obstruction or progression risk.
Seek Prompt Medical Attention If You:
- cannot urinate at all;
- have a painful full lower abdomen with inability to empty your bladder;
- have urinary symptoms together with fever or chills;
- see significant blood in your urine;
- develop severe flank/back pain with urinary illness;
- or develop severe or rapidly worsening urinary symptoms.
Acute urinary retention often requires prompt bladder drainage with a catheter. Drinking less water does not treat a blocked bladder.
Dr. Albana’s Note
When a patient asks me, “What is the best treatment for my enlarged prostate?”, I first try to identify what problem we are actually treating.
If the main problem is a weak stream and hesitancy, the treatment path may be different from a man whose main complaint is urgency and nocturia. If the prostate is clearly enlarged and the risk of future retention is significant, I think differently again because a 5-alpha-reductase inhibitor can change long-term progression risk whereas an alpha blocker cannot.
I also ask about sexual priorities. A man who strongly wants to preserve ejaculation may accept somewhat less symptom improvement or a higher retreatment risk from a minimally invasive procedure. Another patient may prioritize maximum durability and choose HoLEP or another tissue-removing procedure even though dry ejaculation is likely.
Finally, I do not recommend avoiding surgery at all costs. Modern BPH procedures are not simply “last resort” treatments. When symptoms remain unacceptable or a patient wants a durable solution, a procedure can be an entirely reasonable informed choice.
— Dr. Albana Greca, MD, MMedSc, Family Physician / General Practitioner
Most Asked Questions About BPH Treatment
Can BPH be treated without surgery?
Yes. Many men are managed with watchful waiting, lifestyle measures or medication. Procedures become more attractive when symptoms remain troublesome, medicines are unsuitable or ineffective, complications develop, or a patient wants a more durable solution.
Which BPH medicine works fastest?
Alpha blockers generally act fastest, often within days. Finasteride and dutasteride work much more slowly because they gradually reduce DHT-driven prostate growth and shrink an enlarged gland over months.
Which BPH medicine actually shrinks the prostate?
Finasteride and dutasteride are the main evidence-based medicines that reduce prostate volume. Alpha blockers and tadalafil may improve symptoms but do not substantially shrink the gland.
What treatment helps BPH and erectile dysfunction?
Tadalafil 5 mg once daily is guideline-supported for LUTS/BPH with or without erectile dysfunction. It must not be combined with nitrates and is not appropriate in certain unstable cardiovascular conditions.
What is the most durable BPH procedure?
Durability depends on anatomy and technique, but tissue-removing/enucleating procedures such as HoLEP and TURP generally have stronger long-term durability than minimally invasive options such as PUL or water-vapor therapy. HoLEP has particularly low retreatment rates across a broad range of gland sizes when performed by an experienced surgeon.
Which BPH procedures are best for preserving ejaculation?
PUL/UroLift, Rezūm and Aquablation generally have more favorable ejaculation-preservation profiles than TURP or HoLEP. Suitability depends on prostate anatomy and the degree of obstruction, and preservation is never guaranteed.
Does a high PVR automatically mean I need surgery?
No. A high post-void residual can reflect outlet obstruction, weak bladder muscle or both. There is no single PVR cutoff that by itself determines surgery; the result must be interpreted with symptoms, flow, complications and sometimes urodynamic testing.
Does BPH turn into prostate cancer?
No. BPH is benign and does not become prostate cancer. The two conditions can exist independently in the same man.
Related BPH Guides
Medical References
- Goueli R, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and Evaluation. J Urol. 2026;216(2):143-151. PMID 42095481.
- Goueli R, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical Management. J Urol. 2026;216(2):152-160. PMID 42095477.
- Goueli R, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management. J Urol. 2026;216(2):161-170. PMID 42095468.
- European Association of Urology. Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms – Disease Management. 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Enlarged Prostate (Benign Prostatic Hyperplasia).
Medical information notice: This article provides general education and does not replace an examination, diagnosis, prescription or individualized treatment plan. BPH procedures should be selected with a qualified urologist after appropriate evaluation.
Written & medically reviewed by Dr. Albana Greca, MD, MMedSc • Family Physician / General Practitioner • Founder & Lead Medical Author • Last medically reviewed: September 2026